|
End-of-day quote
Other OTC
|
||
| - USD | - |
|
| 21/05 | BioRegenx, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 16/04 | BioRegenx, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 53.44L 46.13L 43.28L 39.42L 74.12L 51Cr 75.15L 5.07Cr 1.99Cr 26Cr 2.01Cr 1.96Cr 85Cr | P/E 2024 |
-0.37x | P/E 2025 | -8.02x |
|---|---|---|---|---|---|
| Enterprise Value | 74.89L 64.65L 60.65L 55.24L 1.04Cr 72Cr 1.05Cr 7.11Cr 2.79Cr 36Cr 2.81Cr 2.75Cr 119.33Cr | EV / Sales 2024 |
4.58x | EV / Sales 2025 | 7.85x |
| Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
William Resides
CEO | Chief Executive Officer | 57 | 08/03/2024 |
Gary Hennerberg
SEC | Corporate Secretary | 69 | 08/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Powers
BRD | Director/Board Member | 71 | 01/01/2012 |
William Resides
BRD | Director/Board Member | 57 | 08/03/2024 |
Suzanne Bird
BRD | Director/Board Member | 61 | 08/03/2024 |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 23.4L 20.2L 18.95L 17.26L 32.46L 22Cr 32.91L 2.22Cr 87.06L 11Cr 87.86L 85.95L 37Cr | 18.55L 16.01L 15.02L 13.68L 25.72L 18Cr 26.08L 1.76Cr 69L 8.88Cr 69.63L 68.12L 30Cr |
| Net income | -2.31Cr -1.99Cr -1.87Cr -1.7Cr -3.2Cr -220.43Cr -3.24Cr -22Cr -8.58Cr -110.43Cr -8.66Cr -8.47Cr -367.35Cr | -15.44L -13.33L -12.5L -11.39L -21.41L -15Cr -21.71L -1.47Cr -57.43L -7.39Cr -57.95L -56.7L -25Cr |
| Net Debt | 21.06L 18.18L 17.06L 15.53L 29.21L 20Cr 29.61L 2Cr 78.35L 10Cr 79.06L 77.35L 34Cr | 21.45L 18.52L 17.37L 15.82L 29.75L 21Cr 30.17L 2.04Cr 79.81L 10Cr 80.54L 78.79L 34Cr |
Employees
-
Sector
-
Select your edition
All financial news and data tailored to specific country editions
















